CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, researchers said on Saturday, raising questions whether th...
Source: http://health.yahoo.net/news/s/nm/merck-blood-clot-drug-in-limbo-after-mixed-results
writing Jesus Receipt design John Edwards
No comments:
Post a Comment
Note: only a member of this blog may post a comment.